PHARMACEUTICAL PREPARATIONS SANITARY PREPARATIONS

Brand Owner (click to sort) Address Description
BALANCE ACTIV Venture Life Healthcare Limited FERN CLOSE PEN-Y-FAN INDUSTRIAL ESTATE UNIT 2 PARKWAY CRUMLIN NP113EF United Kingdom Pharmaceutical preparations and sanitary preparations, namely, vaginal gel for the maintenance of vaginal pH and for deodorant purposes, the foregoing not including preparations, supplements or other products for the treatment of acne or hyperpigmentation or dermatitis conditions, including rosacea, eczema or psoriasis, or for make-up, foundation make-up, skin concealer, face powder, or sunscreen preparations;BALANCE ACTIVE;
KABIVEN FRESENIUS SE Else-Kröner-Strasse 1 61352 Bad Homburg Germany Pharmaceutical preparations and sanitary preparations for medical purposes, namely, dietetic products adapted for medical use, namely, infusion solutions, infusion solutions for nutritional therapy, infusion solutions for parenteral nutrition;
RALF NAGEL NAGEL, RALF Missionsstr. 15 CH-4055 Basel Switzerland Pharmaceutical preparations and sanitary preparations for medical purposes, namely, skin masks, eye gels, day and night creams, moisture gels, hand creams, decollete creams, peeling creams, shower gels, cleaning milks, shampoos, body lotions, eau de parfum, cooling gels, foot creams, muscle creams, cellulite oils, massage oils, deodorants, perfume sprays, energy creams and energy sprays;Soaps; perfumery; essential oils for personal use; cosmetics; hair lotions; and dentifrices;Mineral and aerated waters; energy and sport drinks; fruit drinks; fruit juices; fruit-flavored drinks; and concentrates, syrups or powders used in the preparation of soft drinks;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.